Targeted alpha therapies could better attack tumors while reducing damage to healthy tissue.
Bayer, which acquired Monsanto, the maker of Roundup, is trying to settle all claims, present and future.
Contaminated supply chains, natural disasters, and the bottom line are just some of the reasons why basic drugs are in constant shortage.
Oncology experts say advances in cancer drugs have played a major role.
With the chemical industry challenging the cancer link, the agency has held off on action.
Cause and effect can be difficult to prove, but here are a series of studies showing the potential connection between fracking and health risks.
Sen. McCain is one out of millions of Americans who return to work after cancer treatment or diagnosis.
David Mitchell's advocacy group aims to bring down prescription prices by harnessing the power of patient stories.
A "refreeze" could jeopardize cooperation on cancer drugs.
To treat or not to treat; that is the question.
